Form 4 for ABBV AbbVie
Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-10 · accession 0001179110-21-010956 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-14 | 2021-12-10 | ABBV | Stewart Jeffrey Ryan | EVP, Chief Commercial Off | F - Tax | $124.15 | -1,713 | 49.3K | -3% | -$212.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2021-12-10 | F | D | 1,713 | $124.15 | 49,256 | D | — | — |